BioSensics

Biosensics

Overview

BioSensics is a wearable technology company specializing in developing sensors and monitoring solutions for clinical research and healthcare applications. The company provides advanced wearable devices specifically designed for [Parkinson's disease](/diseases/parkinsons-disease) monitoring, clinical trials, and remote patient monitoring.

Founded with a mission to enable objective, continuous monitoring of movement disorders, BioSensics has established itself as a leading provider of medical-grade wearable sensors for neurological research and clinical care. The company's platform combines hardware sensors, sophisticated algorithms, and cloud-based data analytics to deliver quantifiable insights into patient movement and disease progression["@biosensics"][@pd-wearable].

Company Background

Founding and Mission

BioSensics was founded with the recognition that traditional clinical assessment methods for movement disorders like Parkinson's disease relied heavily on subjective, episodic evaluations that occurred during brief clinic visits. The company's founders sought to create technology enabling:

Biosensics

Overview

BioSensics is a wearable technology company specializing in developing sensors and monitoring solutions for clinical research and healthcare applications. The company provides advanced wearable devices specifically designed for [Parkinson's disease](/diseases/parkinsons-disease) monitoring, clinical trials, and remote patient monitoring.

Founded with a mission to enable objective, continuous monitoring of movement disorders, BioSensics has established itself as a leading provider of medical-grade wearable sensors for neurological research and clinical care. The company's platform combines hardware sensors, sophisticated algorithms, and cloud-based data analytics to deliver quantifiable insights into patient movement and disease progression["@biosensics"][@pd-wearable].

Company Background

Founding and Mission

BioSensics was founded with the recognition that traditional clinical assessment methods for movement disorders like Parkinson's disease relied heavily on subjective, episodic evaluations that occurred during brief clinic visits. The company's founders sought to create technology enabling:

• Continuous, objective monitoring of motor symptoms
• Quantitative measurement of disease progression
• Remote patient monitoring for telehealth applications
• Enhanced data collection for clinical trials

Development History

The company has evolved through several generations of wearable technology:

• First Generation (2010-2014): Research-grade sensors for academic studies
• Second Generation (2014-2018): Clinical-grade devices with regulatory clearances
• Third Generation (2018-Present): Integrated platform with AI-powered analytics

Company Overview

| Attribute | Details |
|-----------|---------|
| Headquarters | United States |
| Founded | Early 2010s |
| Focus | Wearable sensors, Clinical research, Digital health |
| Key Markets | Parkinson's disease, Multiple sclerosis, Clinical trials |
| Products | Wearable sensors, Analytics platform, SDK |

Technology Platform

Hardware: Wearable Sensor Systems

BioSensics develops medical-grade wearable sensors designed for continuous monitoring:

BioSensics PD Monitor

• Accelerometry: High-resolution tri-axial accelerometers for detecting tremor and measuring movement amplitude
• Gyroscopy: Three-axis gyroscopes for rotation and angular velocity measurement
• Magnetometry: Optional magnetometers for orientation tracking
• Form Factor: Wrist-worn, belt-mounted, and ankle-worn configurations

Key Hardware Specifications

• Sampling Rate: 200-1000 Hz for high-fidelity signal capture
• Dynamic Range: ±16g (accelerometer), ±2000°/s (gyroscope)
• Battery Life: 7-14 days of continuous monitoring
• Memory: Local storage for 30+ days of continuous data
• Connectivity: Bluetooth Low Energy for real-time transmission

Sensor Validation

• [MDS-UPDRS](/diseases/parkinsons-disease#mds-updrs) clinical rating scales[@mds-updrs]
• Timed movement tests (tapping, walking)
• Laboratory-based motion capture systems

Algorithms: Machine Learning-Based Analysis

The company's proprietary algorithms process raw sensor data to extract clinically relevant metrics:

Tremor Analysis

• Resting tremor detection: Identification and quantification of resting tremor episodes
• Postural tremor analysis: Detection of tremor during maintained postures
• Kinetic tremor measurement: Quantification of action tremor during movement
• Tremor frequency analysis: Spectral analysis to characterize tremor frequency components[@tremor-detection]

Dyskinesia Detection

• Levodopa-induced dyskinesia: Identification of choreiform movements
• Pattern recognition: Machine learning classifiers trained on expert-labeled data
• Severity scoring: Quantification of dyskinesia intensity and duration

Gait and Balance Assessment

• Gait cycle analysis: Step detection, stride length, swing time
• Balance metrics: Postural sway measurement, fall detection
• Freezing of gait: Detection of episodic gait blocks
• Turn-to-turn analysis: Quantification of turning quality[@gait-analysis]

Bradykinesia Quantification

• Movement speed: Average velocity during finger tapping, hand movements
• Movement amplitude: Range of motion during motor tasks
• Movement rhythm: Inter-tap interval variability

Software: Cloud-Based Analytics

BioSensics provides a comprehensive software platform:

BioSensics Analytics Cloud

• Real-time data processing: Automated analysis as data is collected
• Dashboards: Clinician-facing interfaces for patient monitoring
• Reports: Automated generation of clinical reports
• Alerts: Notification systems for significant changes in symptoms

Integration Capabilities

• API access: For integration with EHR systems
• FHIR support: Healthcare interoperability standards
• Third-party integration: SDK for custom integrations

Clinical Applications

Parkinson's Disease Management

BioSensics technology supports comprehensive PD management:

Continuous Symptom Monitoring

• Motor fluctuations: Tracking of ON/OFF time throughout the day
• Dyskinesia monitoring: Quantification of involuntary movements
• Tremor tracking: Continuous assessment of tremor characteristics
• Gait quality: Ongoing measurement of walking performance

Clinical Decision Support

• Medication optimization: Data-driven adjustments to treatment regimens
• Deep brain stimulation programming: Objective measures for DBS parameter tuning
• Clinical visit preparation: Summary reports for clinic visits

Remote Patient Monitoring

• Telehealth integration: Remote data collection for virtual visits
• Home-based monitoring: Continuous assessment between clinic visits
• Caregiver support: Tools for family members to track patient status[@digital-pd]

Clinical Trials

BioSensics provides endpoints for clinical trials:

Objective Outcome Measures

• Digital biomarkers: Quantifiable measures derived from wearable data
• Continuous endpoints: Measures throughout the trial period vs. episodic clinical assessments
• Remote data collection: Reducing the need for clinic visits[@clinical-trials-wearables]

Trial Services

• Sensor provision: Supplying devices for trial participants
• Data management: Centralized data collection and processing
• Regulatory support: Documentation for regulatory submissions
• Validation studies: Correlation with clinical rating scales

Other Neurological Conditions

While focused on PD, BioSensics technology applies to other conditions:

Multiple Sclerosis

• Gait and balance assessment
• Fatigue monitoring through activity analysis
• Treatment response tracking

Huntington's Disease

• Chorea quantification
• Motor symptom progression monitoring

Ataxia

• Gait analysis for cerebellar ataxias
• Coordination assessment

Essential Tremor

• Tremor characterization
• Treatment response monitoring

Regulatory Status

United States (FDA)

• 510(k) clearances: Multiple device clearances for vital signs monitoring
• De novo pathway: Some PD-specific algorithms under de novo review
• Clinical decision support: FDA-cleared algorithms for symptom detection

European Union (CE Mark)

• CE Mark: Medical device certification under MDR
• Class IIa: Regulatory clearance for clinical monitoring devices

Other Markets

• Health Canada: Medical device license
• PMDA (Japan): Regulatory approval process ongoing

Clinical Validation

BioSensics has demonstrated clinical validity through numerous peer-reviewed publications:

Parkinson's Disease Studies

• Correlation studies between wearable metrics and MDS-UPDRS scores
• Validation in diverse PD populations
• Comparison with gold-standard laboratory assessments

Regulatory-Grade Evidence

• Multi-site validation studies
• Prospective clinical trials
• Real-world evidence collection

Competitive Landscape

BioSensics competes in the digital health wearables space:

Direct Competitors

• Verily Life Sciences: Google-owned health monitoring platform
• Rune Labs: Parkinson's disease monitoring platform
• Great Lakes Neurotechnologies: Movement disorder monitoring
• KinetiWatch: Clinical-grade wearable sensors

Indirect Competition

• Consumer wearables: Apple Watch, Fitbit (limited clinical utility)
• Research systems: XSENS, MVN (research-grade only)

Competitive Advantages

• Clinical validation: Extensive peer-reviewed evidence
• Regulatory clearance: FDA/CE cleared for clinical use
• Focus on PD: Deep expertise in movement disorders
• End-to-end platform: Hardware, software, and analytics

Partnerships

BioSensics has established various partnerships:

Pharmaceutical Companies

• Parkinson's disease clinical trials
• Drug development programs
• Real-world evidence generation

Academic Medical Centers

• Research collaborations
• Clinical validation studies
• Algorithm development partnerships

Medical Device Companies

• Co-development agreements
• Distribution partnerships
• Integration with other medical devices

Healthcare Systems

• Remote patient monitoring programs
• Telehealth integration
• Value-based care initiatives

Product Comparison

| Feature | BioSensics PD Monitor | Consumer Wearables | Research Systems |
|---------|----------------------|-------------------|------------------|
| Clinical Validation | Yes | Limited | Variable |
| FDA Clearance | Yes | No | No |
| Medical Grade | Yes | No | Sometimes |
| Algorithm Accuracy | High | Low | High |
| Continuous Monitoring | Yes | Limited | No |
| Integration | EHR/EMR | Limited | Research |

Future Directions

BioSensics continues to develop:

Emerging Capabilities

• AI-powered prediction: Machine learning for predicting OFF periods
• Multi-modal sensing: Integration of additional sensor modalities
• Personalized algorithms: Individual-specific baseline and anomaly detection

Expansion Areas

• Alzheimer's disease: Monitoring of gait and activity patterns
• Pediatric applications: Developmental movement assessment
• Rehabilitation: Movement quality monitoring during therapy

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)](/proteins/parkin)
• [Digital Health for Neurodegeneration](/topics/digital-health-neurodegeneration)](/diseases/neurodegeneration)
• [Wearable Devices for PD](/topics/wearables-parkinsons)](/proteins/parkin)
• [Rune Labs](/companies/rune-labs)](/companies/rune-labs)
• [Empatica](/companies/empatica)](/companies/empatica)
• [Great Lakes Neurotechnologies](/companies/great-lakes-neurotechnologies)](/technologies)
• [Movement Disorder Monitoring](/topics/movement-disorder-monitoring)

External Links

• [BioSensics Website](https://www.biosensics.com/)](/companies/biosensics)
• [PubMed - Parkinson's Disease Wearables](https://pubmed.ncbi.nlm.nih.gov/?term=parkinson+wearable+sensors)](/proteins/parkin)
• [PubMed - Digital Biomarkers](https://pubmed.ncbi.nlm.nih.gov/?term=digital+biomarkers+parkinson)](/proteins/parkin)
• [MDS-UPDRS Information](https://www.movementdisorders.org/MDS.htm)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving BioSensics discovered through SciDEX knowledge graph analysis: